These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 39008129)

  • 1. Identification of homologs of the Chlamydia trachomatis effector CteG reveals a family of Chlamydiaceae type III secreted proteins that can be delivered into host cells.
    Pereira IS; da Cunha M; Leal IP; Luís MP; Gonçalves P; Gonçalves C; Mota LJ
    Med Microbiol Immunol; 2024 Jul; 213(1):15. PubMed ID: 39008129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Type III Secretion Effector CteG Mediates Host Cell Lytic Exit of
    Pereira IS; Pais SV; Borges V; Borrego MJ; Gomes JP; Mota LJ
    Front Cell Infect Microbiol; 2022; 12():902210. PubMed ID: 35903198
    [No Abstract]   [Full Text] [Related]  

  • 3. CteG is a Chlamydia trachomatis effector protein that associates with the Golgi complex of infected host cells.
    Pais SV; Key CE; Borges V; Pereira IS; Gomes JP; Fisher DJ; Mota LJ
    Sci Rep; 2019 Apr; 9(1):6133. PubMed ID: 30992493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Preliminary Characterization of Novel Type III Secreted Effector Proteins in Chlamydia trachomatis.
    McCaslin PN; Andersen SE; Icardi CM; Faris R; Steiert B; Smith P; Haider J; Weber MM
    Infect Immun; 2023 Jul; 91(7):e0049122. PubMed ID: 37347192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved type III secretion system exerts important roles in Chlamydia trachomatis.
    Dai W; Li Z
    Int J Clin Exp Pathol; 2014; 7(9):5404-14. PubMed ID: 25337183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of type III secretion substrates of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system.
    da Cunha M; Milho C; Almeida F; Pais SV; Borges V; Maurício R; Borrego MJ; Gomes JP; Mota LJ
    BMC Microbiol; 2014 Feb; 14():40. PubMed ID: 24533538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis TmeA Directly Activates N-WASP To Promote Actin Polymerization and Functions Synergistically with TarP during Invasion.
    Keb G; Ferrell J; Scanlon KR; Jewett TJ; Fields KA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468693
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
    Fields KA; Hackstadt T
    Mol Microbiol; 2000 Dec; 38(5):1048-60. PubMed ID: 11123678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DUF582 Proteins of
    Vromman F; Perrinet S; Gehre L; Subtil A
    Front Cell Infect Microbiol; 2016; 6():123. PubMed ID: 27774439
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeted Disruption of Chlamydia trachomatis Invasion by in Trans Expression of Dominant Negative Tarp Effectors.
    Parrett CJ; Lenoci RV; Nguyen B; Russell L; Jewett TJ
    Front Cell Infect Microbiol; 2016; 6():84. PubMed ID: 27602332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis.
    Mueller KE; Fields KA
    PLoS One; 2015; 10(8):e0135295. PubMed ID: 26258949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae.
    Muschiol S; Boncompain G; Vromman F; Dehoux P; Normark S; Henriques-Normark B; Subtil A
    Infect Immun; 2011 Feb; 79(2):571-80. PubMed ID: 21078856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between components of the type III secretion system of Chlamydiaceae.
    Slepenkin A; de la Maza LM; Peterson EM
    J Bacteriol; 2005 Jan; 187(2):473-9. PubMed ID: 15629918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces
    Cossé MM; Barta ML; Fisher DJ; Oesterlin LK; Niragire B; Perrinet S; Millot GA; Hefty PS; Subtil A
    Front Cell Infect Microbiol; 2018; 8():145. PubMed ID: 29868501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis.
    Weber MM; Bauler LD; Lam J; Hackstadt T
    Infect Immun; 2015 Dec; 83(12):4710-8. PubMed ID: 26416906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context-Dependent Action of Scc4 Reinforces Control of the Type III Secretion System.
    Gao L; Cong Y; Plano GV; Rao X; Gisclair LN; Schesser Bartra S; Macnaughtan MA; Shen L
    J Bacteriol; 2020 Jul; 202(15):. PubMed ID: 32424009
    [No Abstract]   [Full Text] [Related]  

  • 17. Type III Secretion in
    Rucks EA
    Microbiol Mol Biol Rev; 2023 Sep; 87(3):e0003423. PubMed ID: 37358451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and targeting of secreted proteins from Chlamydia trachomatis.
    Bauler LD; Hackstadt T
    J Bacteriol; 2014 Apr; 196(7):1325-34. PubMed ID: 24443531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Steiert B; Icardi CM; Faris R; McCaslin PN; Smith P; Klingelhutz AJ; Yau PM; Weber MM
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2303487120. PubMed ID: 37155906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus.
    Hobolt-Pedersen AS; Christiansen G; Timmerman E; Gevaert K; Birkelund S
    FEMS Immunol Med Microbiol; 2009 Oct; 57(1):46-58. PubMed ID: 19682078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.